Answers are grounded in this paper and cite their sources.
To compare medication adherence, lipid goal attainment, and healthcare costs between patients receiving a single-pill combination (SPC) vs. a free combination treatment (FCT) of rosuvastatin/ezetimibe (ROS/EZE) in Italy.
No takes yet. Share an insight, caveat, or question.
Zambon et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: